Introduction
A short four-decade story of extracellular vesicles
Four decades ago, the extracellular medium was considered to be no more than a waste reservoir of cell life, exclusively occurring inside the eukaryotic cell delimited by the plasma membrane.
Here are a few landmarks of the story of extracellular vesicles (EVs): "Exosomes" were first mentioned by R. Johnstone in 1970 and further, thoroughly studied during maturation of reticulocytes1,2. "Shed" vesicles were observed in 19813. Exosomes in blood cells and their function in the transfer of immunity were thoroughly studied in the early 2000s4,5. Clinical observations of exosomes, as normal and pathogenic biomarkers in urine, were first mentioned in 20046. The presence of nucleic acids, mRNAs and microRNAs in exosomes, was pointed out in 20077, as a first strong indication of vesicle-mediated intercellular communication.
The increasing importance of EVs can be evaluated by international meetings devoted first to exosomes in Montreal, Canada in 20058, then in 2011, in the International Workshop on Exosomes in Paris, France9, and more recently, in 2012, to EVs in general, at the first meeting of the International Society of Extracellular Vesicles (ISEV) in Gothenburg, Sweden10. An increasing number of workshops are currently devoted to this exploding field of research.
Why do cells expel extracellular vesicles?
In the absence of a consensus on the nomenclature for various kinds of extracellular vesicles, the term "extracellular vesicles" is used throughout this paper to designate secreted vesicles in general, with no qualification based on defined criteria. For well known subtypes, like exosomes, the more precise qualification is mentioned, when appropriate.
After a widespread observation of many different kinds of extracellular vesicles, emerging from quite different fields of biology and medicine, the modern puzzling questions deal about the life functions of these vesicles.
Why do so many cells expand their action field beyond the cell membrane? Why do cells release vesicles?11. What are the physiological functions of all these EVs? The current state of the art about the role of extracellular vesicles has recently been presented12, whereas exosomes seem to be appealing candidates for mediating intercellular communication13.
Human complexity is indeed much too high to suggest one particular human cell type as a model for understanding the respective roles of the "inside/outside" parts of the cell. To address such a fundamental question requires a convenient well-known eukaryotic model, easy to handle and to follow in a variety of extracellular environments.
A model for the study of eukaryotic extracellular vesicles: Dictyostelium discoideum
About Dictyostelium discoideum
Dictyostelium discoideum came to scientific life in 1935, when it was discovered by Raper14 in the USA Virginia forest, but belongs to a billion year-old Amoeboza lineage, which diverged from the animal-fungal lineage after the plant animal-split15. To survive for such a long time as a unicellular protist, it had to develop a well-conserved life strategy. One of its original biological tricks was to fight against starvation through the first known eukaryotic tentative step towards multicellularity, that is, the aggregation of undifferentiated cells. This aggregation is followed by differentiation into two main cell species: dying stalk cells and "everlasting" spores. Thus, D. discoideum experiences specific time-separated physiological states of growth and differentiation during its life cycle. During growth, as unicellular non-pathogenic amoebae, D. discoideum cells, about 10 µm in diameter, are very similar to some human blood cells; they are often compared to lymphocytes with regard to motility, and to macrophages concerning their capability for phagocytosis. After about 24h of starvation-induced development, through cell aggregation (of about 105 cells), followed by differentiation and morphogenesis, it ends up as a "mushroom-like" organism of 1–2 mm height, forming a fruiting body, composed of a stalk (about 20% of the cells) and a spore bag containing viable spores (about 80% of the cells)16.
Thus, whereas differentiation pulls the microorganism towards a plant-like structure, growing and aggregating cells remain as animal-like cells. Therefore, D. discoideum can offer a simple model of individual eukaryotic cells during growth and also mimic an undifferentiated "tissue" during starvation-induced aggregation. The above-defined "animal" state of D. discoideum during growth and aggregation, completely separated from differentiation, is the first asset of D. discoideum as a model for eukaryotic cells. Some molecular approaches to cell biology using D. discoideum are detailed in Methods in Cell Biology17.
Another advantage of D. discoideum is the good knowledge of its genetic material18. Its 6-chromosome genome has been completely sequenced15. The relatively small genomic DNA (3.4 × 107 bp) is efficiently transcribed (90%) into about 12,500 genes, some of which show analogies with human genes. Its 55.5 kb mitochondrial genome has also been sequenced19. A multicopy 90 kb extrachromosomal element that carries the ribosomal RNA genes, and some plasmids complete the DNA components. The RNA amount is about 10 times the DNA amount and due to this RNA excess, the cell cycle does not require a G1 RNA-synthesis step before the DNA-synthesis S phase. Moreover, Dictyostelium cells can be easily transformed by restriction enzyme-mediated integration (REMI)20.
A third asset of D. discoideum lies in its simple growth conditions. In nature, D. discoideum cells grow by bacterial phagocytosis, with a 3h generation time. A widely used laboratory double axenic mutant, Ax-2, can grow in semi-synthetic HL5-medium21, either as adhering cells or in agitated suspension, with a 8 - 11h generation time. A completely defined medium has also been elaborated22 and is now commercialised, as are many other Dictyostelium growth media (Foremedium, UK). Moreover, D. discoideum cells can reach a density of 2–3 × 107 cells ml-1 in the stationary phase and can also be grown in bioreactors23, when huge amounts of cell materials are needed.
It is worth noting that, owing to all these advantages, D. discoideum was recognised, in 1999, by the National Institutes of Health (NIH, USA) as a new interesting model for biomedical research. Indeed, Dictyostelium had already helped in the understanding of the function of nucleoside diphosphate kinase (NDP) involved in tumour metastasis24,25, and in elucidating the structure of vaults26,27 linked to the drug resistance-related protein LRP28. More recently, R. Escalante gathered various studies that have used D. discoideum as a model for human diseases29. They include pathogen infections, sensitivity to cisplatin and other anticancer drugs, pathobiology of cell motility, lissencephaly, bipolar disorder treatments, lysosomal trafficking and mitochondrial diseases.
Appearance of D. discoideum in the field of extracellular vesicles
Drug detoxification in D. discoideum cells is mediated through release of extracellular vesicles containing the drug. In 1998, it was shown that Dictyostelium cells, known to be highly resistant to xenobiotics, get rid of Hoechst 33342 (HO342), a vital DNA stain for most cells, but not for D. discoideum cells, by means of secretion of extracellular vesicles embedding the dye30. This capability for D. discoideum extracellular vesicle-mediated detoxification has also been checked for hydrophobic drugs, like the photosensitizer hypericin, used in some cancer diagnoses and aimed to photodynamic therapy31.
D. discoideum extracellular vesicles can transfer their vesicular cargos to other cells. Previous studies have found that D. discoideum drug-containing extracellular vesicles are able to transfer HO342 not only to the nuclei of naïve HO342-resistant Dictyostelium cells, but also to the nuclei of human leukaemic multidrug-resistant K562r cells32. In the same way, it it has been shown that hypericin can be transferred from hypericin-containing Dictyostelium extracellular vesicles to the Golgi of tumoral HeLa cells31. Taking into account these experiments, Dictyostelium extracellular vesicles have been proposed as a new biological therapeutic drug delivery tool33,34.
D. discoideum extracellular vesicles are not only a cell detoxifying tool. These vesicles are constitutively released during both growth30 and starvation-induced aggregation35, and are thus candidates for the mediation of intercellular communication.
Quite recently, C. A. Parent found and characterised exosomes during Dictyostelium aggregate formation, suggesting that these organelles are conserved in both Dictyostelium and mammals36,37 (personal communication).
A model to unravel biological functions of eukaryotic extracellular vesicles
In order to use D. discoideum EVs as a model for the functional study of eukaryotic EVs, their characterisation is needed. Recently, these vesicles were used to propose a fast characterisation of EVs by means of three joined techniques: nanoparticle tracking analysis, cryo-electron microscopy and Raman tweezer microspectroscopy38.
With regard to the precise characterisation of Dictyostelium EVs, much remains to be done.
First chacterisations of EVs lipids and nucleic acids30 and of EVs proteins31 have been performed. A more precise protocol for the purification of these extracellular vesicles should be devised, followed by a thorough characterisation of the components of all the different subclasses of D. discoideum extracellular vesicles.
However, before performing a specialised study of each subclass of D. discoideum extracellular vesicles, it is worth questioning the whole distribution panel of EVs accompanying each important physiological state of D. discoideum cell life. R. Gomer was a pioneer in stressing the importance of the conditioned extracellular medium of D. discoideum cells as a source of secreted autocrine factors during both growth and early starvation39,40. He showed that the aggregate sizes were controlled by autocrine protein factors in the extracellular medium41 and showed the presence of autocrine cell growth inhibition42.
Experiments are currently undertaken to test the plausible hypothesis that cells are not programmed to grow, differentiate or die by an apoptotic "clean" death, by their only genomic content and that cells would need intercellular communications to define their individual fate. The necessary signals would be conditioned by all the surrounding cells, according to their own history, and the most convenient way to communicate should indeed be searched for in the cell extracellular medium.
Previously, we found that an apoptotic-like death could be induced with full efficiency by starving a naïve D. discoideum cell population in a conditioned medium. This conditioned medium (t22) was prepared by starving a first D. discoideum cell population in agitated suspension in a phosphate buffer (pH 6.8) for 22 h. When starved in this cell-depleted t22 conditioned medium, the second D. discoideum cell population completely lost its aggregation competence and was directed to an apoptosis-like death35,43. Preliminary (unpublished) experiments indicated that the extracellular vesicles present in the t22 conditioned medium might be responsible for changing the fate of D. discoideum cells from "social" aggregation to mitochondrial-mediated apoptotic death.
In order to understand the important biological communication signals potentially carried by D. discoideum EVs, it is interesting to take advantage of the relative simplicity of this eukaryotic model. D. discoideum is indeed a wonderful tool to question the respective functions of and interplay between extracellular vesicles and soluble secreted autocrine factors in conditioned medium experiments. This should help in understanding the main, still mostly unknown, biological functions of the secreted vesicles.
Conclusion
In 2012, Dictyostelium discoideum was recognized as an interesting model for the study of eukaryotic extracellular vesicles10,44. Due to the important knowledge accumulated on this eukaryotic microorganism since 1935, and to the wide panel of well-defined mutants available in the Stock Center (see dictyBase), a lot of simple experiments can be designed to question the physiological functions of EVs during cell growth, aggregation or apoptotic-like cell death. Moreover, the findings obtained with D. discoideum are likely to be extrapolated to higher eukaryotic cells, in the same way as the extracellular vesicle-mediated detoxification mechanism of D. discoideum cells was a clue towards the introduction of a new multidrug resistance mechanism against antitumoral chemotherapy45.
Competing interests
No relevant competing interests were disclosed.
Grant information
The author(s) declared that no grants were involved in supporting this work.
Acknowledgments
Pierre-Yves Turpin is greatly acknowledged for his helpful assistance in writing the manuscript.
References
- 1.
Johnstone RM, Adam M, Hammond JR, et al.:
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).
J Biol Chem.
1987; 262(19): 9412–20. PubMed Abstract
- 2.
Johnstone RM, Mathew A, Mason AB, et al.:
Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins.
J Cell Physiol.
1991; 147(1): 27–36. PubMed Abstract
| Publisher Full Text
- 3.
Trams EG, Lauter CJ, Salem N Jr, et al.:
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles.
Biochim Biophys Acta.
1981; 645(1): 63–70. PubMed Abstract
| Publisher Full Text
- 4.
Stoorvogel W, Kleijmeer MJ, Geuze HJ, et al.:
The biogenesis and functions of exosomes.
Traffic.
2002; 3(5): 321–30. PubMed Abstract
| Publisher Full Text
- 5.
Théry C, Zitvogel L, Amigorena S:
Exosomes: composition, biogenesis and function.
Nat Rev Immunol.
2002; 2(8): 569–79. PubMed Abstract
| Publisher Full Text
- 6.
Pisitkun T, Shen RF, Knepper MA:
Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci U S A.
2004; 101(36): 13368–73. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 7.
Valadi H, Ekstrom K, Bossios A, et al.:
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol.
2007; 9(6): 654–9. PubMed Abstract
| Publisher Full Text
- 8.
Couzin J:
Cell biology: The ins and outs of exosomes.
Science.
2005; 308(5730): 1862–3. PubMed Abstract
| Publisher Full Text
- 9.
IWE. Final Program IWE 2011. International Workshop on Exosomes (IWE) 2011. January 19–22, Paris, France. Reference Source
- 10.
ISEV.Abstracts from the First International Meeting of the International Society for Extracellular Vesicles 2012. Gothenburg, Sweden.
Journal of Extracellular Vesicles
2012; 1. Publisher Full Text
- 11.
Nieuwland R, Sturk A:
Why do cells release vesicles?
Thromb Res.
2010; 125(Suppl 1): S49–51. PubMed Abstract
| Publisher Full Text
- 12.
Gyorgy B, Szabo TG, Pasztoi M, et al.:
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.
Cell Mol Life Sci.
2011; 68(16): 2667–88. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 13.
Théry C:
Exosomes: secreted vesicles and intercellular communications.
F1000 Biol Rep.
2011; 3(15). PubMed Abstract
| Publisher Full Text
| Free Full Text
- 14.
Raper KB:
A new species of slime mold from decaying forest leaves.
J Agr Research.
1935; 50: 135–147.
- 15.
Eichinger L, Pachebat JA, Glockner G, et al.:
The genome of the social amoeba Dictyostelium discoideum.
Nature.
2005; 435(7038): 43–57. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 16.
Loomis WF:
Dictyostelium discoideum: A developmental System. New York: Academic Press, Inc. 1975; 214p. Reference Source
- 17.
Spudich JA:
Dictyostelium discoideum: Molecular Approaches to Cell Biology. London: Academic Press, Inc.
Methods Cell Biol.
1987; 28: 1–516PubMed Abstract
- 18.
Loomis WF, Kuspa A:
The genome of Dictyostelium discoideum, in Dictyostelium: A model System for Cell and Developmental Biology. Proceedings of the Yamada Conference XLVI on International Dictyostelium Conference, October 14–18, Sendai, Japan, Maeda Y, Inouye K, Takeuchi I, Editors. Universal Academy Press, Inc: Tokyo, Japan 1996; p. 15–30.
- 19.
Ogawa S, Yoshino R, Angata K, et al.:
The mitochondrial DNA of Dictyostelium discoideum: complete sequence, gene content and genome organization.
Mol Gen Genet.
2000; 263(3): 514–9. PubMed Abstract
| Publisher Full Text
- 20.
Kuspa A, Loomis WF:
Tagging developmental genes in Dictyostelium by restriction enzyme-mediated integration of plasmid DNA.
Proc Natl Acad Sci U S A.
1992; 89(18): 8803–7. PubMed Abstract
| Publisher Full Text
- 21.
Watts DJ, Ashworth JM:
Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture.
Biochem J.
1970; 119(2): 171–4. PubMed Abstract
| Free Full Text
- 22.
Franke J, Kessin R:
A defined minimal medium for axenic strains of Dictyostelium discoideum.
Proc Natl Acad Sci U S A.
1977; 74(5): 2157–61. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 23.
Lu Y, Knol JC, Linskens MH, et al.:
Production of the soluble human Fas ligand by Dictyostelium discoideum cultivated on a synthetic medium.
J Biotechnol.
2004; 108(3): 243–51. PubMed Abstract
| Publisher Full Text
- 24.
Liotta LA, Steeg PS:
Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum.
J Natl Cancer Inst.
1990; 82(14): 1170–2. PubMed Abstract
| Publisher Full Text
- 25.
Wallet V, Mutzel R, Troll H, et al.:
Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development.
J Natl Cancer Inst.
1990; 82(14): 1199–202. PubMed Abstract
| Publisher Full Text
- 26.
Kedersha NL, Miquel MC, Bittner D, et al.:
Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes.
J Cell Biol.
1990; 110(4): 895–901. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 27.
Vasu SK, Rome LH:
Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein.
J Biol Chem.
1995; 270(28): 16588–94. PubMed Abstract
| Publisher Full Text
- 28.
Scheffer GL, Wijngaard PL, Flens MJ, et al.:
The drug resistance-related protein LRP is the human major vault protein.
Nat Med.
1995; 1(6): 578–82. PubMed Abstract
| Publisher Full Text
- 29.
Escalante R:
Dictyostelium as a model for human disease.
Semin Cell Dev Biol.
2011; 22(1): 69–130. PubMed Abstract
| Publisher Full Text
- 30.
Tatischeff I, Bomsel M, de Paillerets C, et al.:
Dictyostelium discoideum cells shed vesicles with associated DNA and vital stain Hoechst 33342.
Cell Mol Life Sci.
1998; 54(5): 476–87. PubMed Abstract
| Publisher Full Text
- 31.
Lavialle F, Deshayes S, Gonnet F, et al.:
Nanovesicles released by Dictyostelium cells: a potential carrier for drug delivery.
Int J Pharm.
2009; 380(1–2): 206–15. PubMed Abstract
| Publisher Full Text
- 32.
Tatischeff I, Lavialle F, Pigaglio-Deshayes S, et al.:
Dictyostelium extracellular vesicles containing Hoechst 33342 transfer the dye into the nuclei of living cells: a fluorescence study.
J Fluoresc.
2008; 18(2): 319–28. PubMed Abstract
| Publisher Full Text
- 33.
Tatischeff I, Alfsen A:
A New Biological Strategy for Drug Delivery: Eucaryotic Cell-Derived Nanovesicles.
J Biomater Nanobiotechnol.
2011; 2(5): 494–9. Publisher Full Text
- 34.
Tatischeff I, Alfsen A, Lavialle F:
Extracellular vesicles from non-pathogenic amoeba useful as vehicle for transferring a molecule of interest to an eukaryotic cell. (DRITT-UPMC) 2003–2012: European Priority No. 03 291 752. European Patent (Danemark, Deutschland, France, Great Britain, Italy, Netherland, Spain) USA and Canada Patents.
- 35.
Tatischeff I, Petit PX, Grodet A, et al.:
Inhibition of multicellular development switches cell death of Dictyostelium discoideum towards mammalian-like unicellular apoptosis.
Eur J Cell Biol.
2001; 80(6): 428–41. PubMed Abstract
| Publisher Full Text
- 36.
EM. Exosomes and Microvesicles 2012 Conference. Orlando, Florida, USA September 29th October 2nd 2012. Reference Source
- 37.
Kriebel PW, Jenkins L, Zhang L, et al.:
Isolation and proteomic analysis of Dictyostelium exosomes in Exosome and Microvesicles Conference. Orlando, Florida USA, 2012.
- 38.
Tatischeff I, Larquet E, Falcon-Pérez JM, et al.:
Fast characterisation of cell-derived extracellular vesicles by nanoparticles tracking analysis, cryo-electron microscopy, and Raman tweezers microspectroscopy.
J Extracellular Vesicles.
2012; 1: 19179. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 39.
Clarke M, Dominguez N, Yuen IS, et al.:
Growing and starving Dictyostelium cells produce distinct density-sensing factors.
Dev Biol.
1992; 152(2): 403–6. PubMed Abstract
| Publisher Full Text
- 40.
Clarke M, Gomer RH:
PSF and CMF, autocrine factors that regulate gene expression during growth and early development of Dictyostelium.
Experientia.
1995; 51(12): 1124–34. PubMed Abstract
| Publisher Full Text
- 41.
Brock DA, van Egmond WN, Shamoo Y, et al.:
A 60-kilodalton protein component of the counting factor complex regulates group size in Dictyostelium discoideum.
Eukaryot Cell.
2006; 5(9): 1532–8. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 42.
Choe JM, Bakthavatsalam D, Phillips JE, et al.:
Dictyostelium cells bind a secreted autocrine factor that represses cell proliferation.
BMC Biochem.
2009; 10: 4. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 43.
Arnoult D, Tatischeff I, Estaquier J, et al.:
On the evolutionary conservation of the cell death pathway: mitochondrial release of an apoptosis-inducing factor during Dictyostelium discoideum cell death.
Mol Biol Cell.
2001; 12(10): 3016–30. PubMed Abstract
| Publisher Full Text
| Free Full Text
- 44.
Tatischeff I, Kruglik S, Larquet E, et al.:
Microvesicles of Dictyostelium discoideum as a model of eukaryotic extracellular vesicles. ISEV: F1000 Posters2012; 3. : 427. Reference Source
- 45.
Tatischeff I:
Cell-derived microvesicles and antitumoral multidrug resistance.
C R Biol.
2012; 335(2): 103–6. PubMed Abstract
| Publisher Full Text
Comments on this article Comments (0)